NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Stock Market Recap: Bears Continue to Dominate

The stock market saw a continuation of the selling pressure that has been plaguing investors, with no signs of easing in sight. The bears have extended their onslaught, cutting off any attempt at a recovery. This trend is largely attributed to the ongoing uncertainty surrounding the West Asia war, which continues to weigh heavily on market sentiment.

As a result, the bullish bias that had been present in the market has been punctured once again, leaving investors to focus on rebuilding conditions necessary for even a modest recovery. The uncertainty surrounding the West Asia war is likely to persist, and its impact on the market is expected to continue in the near term.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should be cautious and wait for a recovery in market sentiment before making any investment decisions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.